- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Terrill Jordan on Implementing OCM: Take It Step by Step
Before undertaking something like implementing the Oncology Care Model, practices should understand the scope of the project and the overall importance it can have for patient care, said Terrill Jordan, CEO of Regional Cancer Care Associates.
Before undertaking something like implementing the Oncology Care Model, practices should understand the scope of the project and the overall importance it can have for patient care, said Terrill Jordan, CEO of Regional Cancer Care Associates.
Transcript
What do you want others to know about implementing OCM?
I think overall that the challenges that we would want others to know about it is that the planning of something like this is a daunting exercise. It can overwhelm a practice, so you have to take each step one step by step. You can’t allow yourself to bite off too much at any given time. That’s one piece.
The other piece is just to understand that this is a long-term commitment and we have extended enormous resource here, both in personnel and in infrastructure and we need to know that in the end it was all worth something and that we are not going to jettison a program such as this or any of the value-based programs because we believe that it is the best thing for the patient. We believe the patient gets a better experience, better care, and it’s also great for our clinicians because they are more engaged and they are doing what they want to do which is manage clinical outcomes for their patients.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Finding the Right Biomarker Is Key to the TIGIT Puzzle, Experts Say
May 12th 2025Data for SKYSCRAPER-01, involving the anti-TIGIT antibody tiragolumab, align with recent bad news for this once-promising therapeutic target. But investigators involved in TIGIT studies say the problem is finding the right biomarker.
Read More
